Metagenomic fingerprints in bronchoalveolar lavage differentiate pulmonary diseases.

Journal: NPJ digital medicine

This study presents a multimodal machine learning approach using metagenomic next-generation sequencing (mNGS) data from bronchoalveolar lavage fluid to differentiate lung cancer from various pulmonary infections, including bacterial, fungal, and tuberculosis.

By analyzing multiple factors, the integrated model examines:

  • Microbial profiles
  • Host gene expression
  • Immune cell composition
  • Tumor-related genetic alterations

The model demonstrated high diagnostic performance, achieving area under the curve (AUC) values of 0.937 in the training cohort and 0.847 in the testing cohort.

Additionally, implementing a rule-in/rule-out strategy further improved accuracy, reaching over 89% across different infection types.

These results suggest that mNGS-based multimodal analysis is a promising, cost-effective method for early and precise differential diagnosis in lung diseases.

Leave a Reply